GlobeNewswire 2019-05-06 Novan Completes Funding Transaction with Ligand Pharmaceuticals
GlobeNewswire 2019-03-11 Sermonix to Present at Boston Oncology Investor Conference on Potential for Lasofoxifene in Metastat...
GlobeNewswire 2019-03-11 Sermonix to Present at Boston Oncology Investor Conference on Potential for Lasofoxifene in Metastat...
GlobeNewswire 2019-03-08 UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions
GlobeNewswire 2019-03-08 electroCore Appointments Multiple Industry Veterans to Key Management Positions
GlobeNewswire 2019-03-05 Detailed Research: Economic Perspectives on Twenty-First Century Fox, Acadia Healthcare, Targa Resou...
GlobeNewswire 2019-03-04 Sermonix to Present Poster at ENDO 2019 on Lasofoxifene’s ‘Potent Anti-Tumor Activity’ in ESR1 Hormo...
GlobeNewswire 2019-02-26 Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical ...
GlobeNewswire 2019-02-01 Consolidated Research: 2019 Summary Expectations for Micron Technology, Quidel, Ligand Pharmaceutica...
GlobeNewswire 2019-01-29 Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of...
GlobeNewswire 2019-01-24 Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, In...
GlobeNewswire 2019-01-17 Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of...
GlobeNewswire 2019-01-17 SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ligand Pharmaceutic...
GlobeNewswire 2018-12-18 Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX...
GlobeNewswire 2018-12-11 Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments
GlobeNewswire 2018-12-10 Sermonix Announces FDA Acceptance of IND Application; Will Begin Phase 2 Trial of Lasofoxifene for T...
GlobeNewswire 2018-11-14 Sermonix Pharmaceuticals to Present Three Posters Focused on Precision Medicine in the Treatment of ...
GlobeNewswire 2018-10-15 Contrast Agents/Media Market, 2025
GlobeNewswire 2018-10-09 Sermonix Launches Phase 2 Trial to Evaluate Investigational Oral Lasofoxifene as a Targeted Precisio...
GlobeNewswire 2018-09-19 Antibody Discovery Services and Platforms Market, 2028
GlobeNewswire 2018-09-10 Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financin...
GlobeNewswire 2018-09-05 Global Bi-Specific Antibodies Market Forecast to 2022 - Increasing Demand for Bi-Specific/Double Bar...
GlobeNewswire 2018-09-05 Palvella Therapeutics Appoints Rare Disease Senior Executive Elaine J. Heron, PhD to Board of Direct...
GlobeNewswire 2018-08-10 Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...
GlobeNewswire 2018-07-30 Sedor Pharmaceuticals NDA for CE-Fosphenytoin for Status Epilepticus Receives PDUFA Date